Exploring Explainable AI to Enhance Antibiotic Discovery
Explainable AI offers transparency in AI-driven drug discovery, providing insights into antibiotic development.
- Latest
- Trending
Explainable AI offers transparency in AI-driven drug discovery, providing insights into antibiotic development.
Battelle has advanced a new technology to effectively eliminate PFAS, addressing the persistent 'forever chemicals' issue.
AI-designed proteins transform with molecular switches, paving new paths in biotechnology innovation and drug delivery.
Recursion Pharmaceuticals merges with Exscientia to revolutionize drug discovery, bringing new treatments to market more quickly.
Discover Piper Sandler's eight high-quality defensive biotech stocks poised to thrive in volatile markets.
AbCellera Biologics Inc. progresses with their TCE platform and strategic partnerships, aiming for CTA submissions in Q2 2025.
America's crackdown on Chinese biotech could lead to drug shortages and higher costs, impacting patients without delivering promised security benefits.
AI is revolutionizing healthcare, finance, and more, say NVIDIA's Trivedi and Uniphore's Sachdev, showcasing efficiency and cost savings across sectors.
Precision fermentation is a pioneering biotech process for creating bio-based materials. Danone plans to debut demo-scale production by 2025, expanding ...
Researchers have successfully developed a single-dose vaccine that prompts the production of T-cells and "memory" B cells to fight against ...
We are building the future together with you. We write content with maximum speed and excellent quality. Each material is accompanied by an analyst's commentary.